Suraksha Diagnostic Limited

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about a newspaper publication regarding the Notice of the 21st Annual General Meeting of the Company scheduled to be held on September 22, 2026, and e-voting information.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has announced the 21st Annual General Meeting (AGM) to be held on September 22, 2026, through Video Conference (VC) / Other Audio Visual Means (OAVM). The company has also made available the Annual Report for the Financial Year 2025-26 on its website and on the websites of the stock exchanges where its securities are listed.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has announced its 21st Annual General Meeting (AGM) to be held on September 22, 2026, with the Annual Report for FY 2025-26, including Notice for the AGM, being sent to members through electronic mode. The report is also available on the company's website.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about the submission of a newspaper publication for the notice of its 21st Annual General Meeting (AGM) for FY 2025-26, scheduled to be held on 22 September, 2026.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about the submission of newspaper publications for the notice of the 21st Annual General Meeting (AGM) for FY 2025-26, scheduled to be held on 22 September, 2026.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has reported a strong start to FY '27 with 21% revenue growth, 28% EBITDA growth, and 40% PAT growth in Q1 FY '27. The company has also demonstrated encouraging traction in its Genomics vertical with 136% year-on-year growth.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call held on 24th February 2023.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about the link of recording of the Analysts/Institutional Investor Meet/Con. Call held on 13 August 2026, regarding the unaudited financial results for the quarter ended 30 June 2026 and other business discussions. The audio recording is available on the company's website.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about the link of recording of their analysts/institutional investor meet/con. call updates, specifically the earnings call held on 13 August 2026, related to their unaudited financial results for the quarter ended 30 June 2026.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about the unaudited financial results for the quarter ended 30 June 2026, and Sundaram Mutual Fund has announced changes in fund management responsibilities.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 40% year-on-year growth in PAT and 28% growth in EBITDA.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation for Q1 FY27 results, with 21% revenue growth, 36% EBITDA margin, and 14.7% PAT margin.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has announced the record date for the purpose of dividend as 15-Sep-2026.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has informed the Exchange regarding the appointment of Mr. Dinesh Gupta as Chief Financial Officer of the company with effect from August 24, 2026. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the appointment of Mr. Dinesh Gupta as the Chief Financial Officer, effective from August 24, 2026. The company has also fixed September 15, 2026, as the record date for determining the entitlement of shareholders to receive dividend for the financial year ended March 31, 2026.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and approved the appointment of a new Chief Financial Officer.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has postponed its 21st Annual General Meeting due to unavoidable circumstances. The revised date, time, and venue will be decided in due course and informed to the stock exchanges and shareholders accordingly.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited will host a conference call for analysts and investors to discuss their Q1 FY27 results on Thursday, 13th August 2026, at 11:30 AM IST.

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has received a certificate under SEBI (Depositories and Participants) Regulations, 2018, from its registrar and share transfer agent, KFin Technologies Limited, for the quarter ended June 30, 2026, confirming the details of securities dematerialized or rematerialized during the period.